Laboratory Corp of America Holdings

Healthcare
$249.34
-5.65 (2.22%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$253.90$254.99480,581544,519

Fundamentals

Market Cap$22.09B
P/B Ratio2.2
P/E Ratio12.6
Enterprise Value$27.95B
Div. Yield1.13%
Book Value113.91
EPS(TTM)3.91
ROENA
Understand Fundamentals

About the Company

Popularly known as LabCorp, Laboratory Corporation of American Holdings functions as an independent clinical laboratory. Its headquarters are stationed in Burlington, North Carolina, and it operates with a network of 36 primary laboratories in the United States. This company has over 70,000 employees, and its clientele is based in over 100 countries globally. It is acknowledged as one of the pioneers of genomic testing that uses polymerase chain reaction (PCR) technology. This company caters to many customers, including doctors, contract research organisations, hospitals, drug companies, government agencies, food and nutritional companies and independent clinical labs. It is accredited for processing diagnostic tests of more than 3 million patient specimens every week. This company operates through two major segments, namely LabCorp Diagnostics and Covance Drug Development. The first segment offers more than 5000 tests, which accounts for around 60% of this company's annual revenue. On the other hand, Covance Drug Development is involved with extending end-to-end drug development, associated diagnostics development solutions and medical devices. Its pre-clinical laboratories are based in Indiana, Wisconsin, Michigan, and Virginia. LabCorp extends multiple services like routine urinalyses, Pap smears and HIV tests. It also provides speciality testing for forensics, identity, genetics, clinical drug trials, disease monitoring, allergies, etc. National Health Laboratories was first publicly traded on NASDAQ in 1988. However, in 1991, this company moved from NASDAQ to the New York Stock Exchange (NYSE) and began to trade under the ticker symbol NH. Subsequently, in 1993, it became a part of the S&P MidCap 400 list. The National Health Laboratories Inc. was reorganised as a holding company, named, National Health Laboratories Holdings Inc. in 1994. However, the company's name was changed to its current one after its merger with Roche Biomedical Laboratories, Inc. in 1995. Following this, the Laboratory Corporation of America Holdings shares were traded on the stock exchange under the ticker symbol “LH”. In 2019, this company acquired MNG Lab based in Georgia to improve its neurology and neurogenetics-related capabilities as the lab specialises in complex biochemical testing. LabCorp has made 24 acquisitions over the years; some of the most noteworthy ones include Chiltern International, Dianon Systems, Safe Food International, Tandem Labs, Genzyme Genetics, Pathology Associates Medical Laboratories, Sequenom, etc.;
OrganisationLaboratory Corp of America Holdings
IndustryDiagnostics & Research
HeadQuartersBurlington, NC

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Want to invest in US Stocks?
Signup with Groww to get started
Login / Register
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI